Table 3.
Matrix | Analyte | Conc. (ng/ml) | AR (%) | RR (%) | ME (%) | Type |
---|---|---|---|---|---|---|
| ||||||
Plasma | COT | 3.0 | 37.26±1.20 | 52.94±1.71 | 70.38 | 29.62% suppression |
30.0 | 23.82±8.41 | 40.54±14.31 | 58.75 | 41.25% suppression | ||
75.0 | 30.79±7.42 | 41.97±10.12 | 73.36 | 26.64% suppression | ||
| ||||||
NCOT | 3.0 | 62.42±5.66 | 76.80±6.97 | 81.28 | 18.72% suppression | |
30.0 | 63.41±9.13 | 83.90±12.09 | 75.57 | 24.43% suppression | ||
75.0 | 66.51±8.04 | 73.55±8.89 | 90.43 | 9.57% suppression | ||
| ||||||
OHCOT | 3.0 | 36.04±2.32 | 89.51±5.75 | 40.26 | 59.74% suppression | |
30.0 | 37.09±12.42 | 73.61±24.66 | 50.38 | 49.62% suppression | ||
75.0 | 41.56±3.49 | 76.77±6.45 | 54.14 | 45.86% suppression | ||
| ||||||
COTNO | 3.0 | 33.54±9.73 | 41.81±12.14 | 80.22 | 19.78% suppression | |
30.0 | 45.83±2.21 | 56.99±2.75 | 80.41 | 19.59% suppression | ||
75.0 | 34.56±4.00 | 45.06±5.21 | 76.69 | 23.31% suppression | ||
| ||||||
Brain | COT | 3.0 | 41.27±4.39 | 58.75±6.24 | 70.25 | 29.75% suppression |
30.0 | 30.88±2.73 | 37.60±3.33 | 82.12 | 17.88% suppression | ||
75.0 | 39.15±3.38 | 63.01±5.43 | 62.12 | 37.88% suppression | ||
| ||||||
NCOT | 3.0 | 60.35±1.79 | 75.38±2.23 | 80.07 | 19.93% suppression | |
30.0 | 65.68±1.35 | 96.80±2.00 | 67.85 | 32.15% suppression | ||
75.0 | 71.84±4.98 | 97.27±6.75 | 73.86 | 26.14% suppression | ||
| ||||||
OHCOT | 3.0 | 27.50±1.82 | 78.61±5.19 | 34.98 | 65.02% suppression | |
30.0 | 41.30±2.91 | 82.95±5.85 | 49.79 | 50.21% suppression | ||
75.0 | 36.45±1.23 | 100.03±3.36 | 36.44 | 63.56% suppression | ||
| ||||||
COTNO | 3.0 | 19.96±5.08 | 31.88±8.11 | 62.61 | 37.39% suppression | |
30.0 | 39.24±6.20 | 68.00±10.74 | 57.71 | 42.29% suppression | ||
75.0 | 25.30±7.23 | 39.69±11.35 | 63.74 | 36.26% suppression |